Dacar Cas/Somali Red Aloe: a new species of (Asphodelaceae) from Somaliland.

A new species of Aloe (Asphodelaceae) is described from Somaliland. It differs from other species in forming large clumps and in having sap that is initially yellow but quickly turns bright red and then dark red or reddish-brown, paniculate red-flowered inflorescences and uniformly coloured leaves with red teeth. Its recognition raises the number of species known from the combined area of Somaliland and Somalia s.

Piptochaetium fuscum (Nees ex Steud.) Barkworth, Ciald., & Gandhi, a new combination replacing Piptochaetium setosum (Trin.) Arechav.

A new name, Piptochaetium fuscum, is provided for a taxon hitherto known as Piptochaetium setosum (Trin.) Arechav. Morphological, anatomical, and molecular studies that argue against including Piptochaetium in Stipa, and hence use of S.

The US Virtual Herbarium: working with individual herbaria to build a national resource.

The goal of the US Virtual Herbarium (USVH) project is to digitize (database, image, georeference) all specimens in all US herbaria, enabling them to be made available through a single portal. Herbaria house specimens of plants, fungi, and algae, so USVH will offer a rich portrait of biodiversity in the US and in the other countries represented in US herbaria. Equally importantly, working towards this goal will engage people with herbaria and the organisms they house, expanding their appreciation of both the power of biodiversity informatics and the demands that it places on data providers while developing improved communication among those working in and with herbaria.

Bioequivalence study of generic tablet formulations containing ethinylestradiol and chlormadinone acetate in healthy female volunteers.

The bioavailability and bioequivalence of two different film coated tablets containing ethinylestradiol (CAS 57-63-6) and chlormadinone acetate (CAS 302-22-7) (Bellissima as test and the respective preparation from the originator as reference) were investigated in 20 healthy female volunteers after oral single-dose administration. The study was performed according to a single-center, randomised, single-dose, 2-way cross-over design with a wash-out phase of 28 days. Blood samples for pharmacokinetic profiling were taken up to 168 h post-dose, and ethinylestradiol and chlormadinone acetate plasma concentrations were determined with a validated LC-MS/MS method.

Bioequivalence study with two different oral formulations of methocarbamol in healthy subjects. A mono-centre, comparative, randomized, open-label, single-dose, 2-way crossover study.

Objective: The objective of this study was to compare the pharmacokinetic profile of a new oral methocarbamol (CAS 532-03-6) formulation (DoloVisano Methocarbamol 750 mg Tabletten) to that of a registered reference product and to demonstrate the bioequivalence of the formulations with respect to rate and extent of methocarbamol exposure.

Method: This bioequivalence trial was based on an open-label, single-dose, randomized, two-treatment, two-period crossover design. In each period 32 male or female healthy white volunteers received 2 tablets (2 x 750 mg methocarbamol) of either the test (a) or the reference (b) product after an overnight fasting of at least 12 h.